Watson’s Ipratropium Bromide and Albuterol Sulfate product is the generic equivalent to Dey’s DuoNeb, which is indicated for the treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) in patients requiring more than one bronchodilator. Watson intends to launch its Ipratropium Bromide and Albuterol Sulfate product immediately.